{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:12:34Z","timestamp":1724112754872},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,19]]},"DOI":"10.7759\/cureus.67164","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T07:20:25Z","timestamp":1724052025000},"source":"Crossref","is-referenced-by-count":0,"title":["Surveillance of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Clinical Isolates in a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Chakrapani","family":"Kammineni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreeja","family":"Vamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreekanth Reddy","family":"Basireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli E","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018, 18:318-27. 10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041762","article-title":"A comprehensive overview of the antibiotics approved in the last two decades: retrospects and prospects","volume":"28","author":"Shi Z","year":"2023","unstructured":"Shi Z, Zhang J, Tian L, Xin L, Liang C, Ren X, Li M. A comprehensive overview of the antibiotics approved in the last two decades: retrospects and prospects. Molecules. 2023, 28:10.3390\/molecules28041762","journal-title":"Molecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa034","article-title":"Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals","volume":"75","author":"Lepore L","year":"2020","unstructured":"Lepore L, Fabrizio C, Bavaro DF, et al.. Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals. J Antimicrob Chemother. 2020, 75:1580-7. 10.1093\/jac\/dkaa034","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00296-5","article-title":"Cefiderocol: a novel agent for managing multidrug-resistant Gram-negative bacteria","volume":"9","author":"Wu JY","year":"2020","unstructured":"Wu JY, Srinivas P, Pogue JM. Cefiderocol: a novel agent for managing multidrug-resistant Gram-negative bacteria. Infect Dis Ther. 2020, 9:17-40. 10.1007\/s40121-020-00296-5","journal-title":"Infect Dis Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato T","year":"2019","unstructured":"Sato T, Yamawaki K. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis. 2019, 69:S538-43. 10.1093\/cid\/ciz826","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01580-4","article-title":"Cefiderocol: a review in serious Gram-negative bacterial infections","volume":"81","author":"Syed YY","year":"2021","unstructured":"Syed YY. Cefiderocol: a review in serious Gram-negative bacterial infections. Drugs. 2021, 81:1559-71. 10.1007\/s40265-021-01580-4","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01649-20","article-title":"Cefiderocol antimicrobial susceptibility testing against multidrug-resistant Gram-negative bacilli: a comparison of disk diffusion to broth microdilution","volume":"59","author":"Morris CP","year":"2020","unstructured":"Morris CP, Bergman Y, Tekle T, Fissel JA, Tamma PD, Simner PJ. Cefiderocol antimicrobial susceptibility testing against multidrug-resistant Gram-negative bacilli: a comparison of disk diffusion to broth microdilution. J Clin Microbiol. 2020, 59:10.1128\/JCM.01649-20","journal-title":"J Clin Microbiol"},{"key":"ref8","article-title":"Performance Standards for Antimicrobial Susceptibility Testing; Thirty-Fourth Informational Supplement","year":"2024","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing; Thirty-Fourth Informational Supplement. Clinical and Laboratory Standards Institute, Wayne; 2024."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis S","year":"2022","unstructured":"Karakonstantis S, Rousaki M, Kritsotakis EI. Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics (Basel). 2022, 11:10.3390\/antibiotics11060723","journal-title":"Antibiotics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030614","article-title":"Comparison of broth microdilution, disk diffusion and strip test methods for cefiderocol antimicrobial susceptibility testing on KPC-producing Klebsiella pneumoniae","volume":"12","author":"Bovo F","year":"2023","unstructured":"Bovo F, Lazzarotto T, Ambretti S, Gaibani P. Comparison of broth microdilution, disk diffusion and strip test methods for cefiderocol antimicrobial susceptibility testing on KPC-producing Klebsiella pneumoniae. Antibiotics (Basel). 2023, 12:10.3390\/antibiotics12030614","journal-title":"Antibiotics (Basel)"},{"key":"ref11","article-title":"Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution","volume":"77","year":"2022","unstructured":"Cefiderocol. EUCAST criteria for disc diffusion and broth microdilution. J Antimicrob Chemother. 2022, 77:1662-9.","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02712-21","article-title":"In vitro activity of cefiderocol against U.S. and European Gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program","volume":"10","author":"Shortridge D","year":"2022","unstructured":"Shortridge D, Streit JM, Mendes R, Castanheira M. In vitro activity of cefiderocol against U.S. and European Gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program. Microbiol Spectr. 2022, 10:e0271221. 10.1128\/spectrum.02712-21","journal-title":"Microbiol Spectr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa117","article-title":"Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia","volume":"75","author":"Delgado-Valverde M","year":"2020","unstructured":"Delgado-Valverde M, Conejo MD, Serrano L, Fern\u00e1ndez-Cuenca F, Pascual \u00c1. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Antimicrob Chemother. 2020, 75:1840-9. 10.1093\/jac\/dkaa117","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00847-23","article-title":"In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam\/aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India","volume":"11","author":"Borde K","year":"2023","unstructured":"Borde K, Kareem MA, Sharma RM, Dass SM, Ravi V, Mathai D. In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam\/aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India. Microbiol Spectr. 2023, 11:e0084723. 10.1128\/spectrum.00847-23","journal-title":"Microbiol Spectr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2023.100556","article-title":"In vitro activity of the newly approved antimicrobial agent Cefiderocol against carbapenem-resistant Gram-negative clinical isolates","volume":"48","author":"Khanchandani H","year":"2024","unstructured":"Khanchandani H, Chaudhury M, Rao MS, Ramakrishna N, Venkataramana B, Chaudhury A. In vitro activity of the newly approved antimicrobial agent Cefiderocol against carbapenem-resistant Gram-negative clinical isolates. Indian J Med Microbiol. 2024, 48:100556. 10.1016\/j.ijmmb.2023.100556","journal-title":"Indian J Med Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S366829","article-title":"Analysis of in vitro activity of cefiderocol against carbapenem-resistant Gram-negative bacilli by broth microdilution and disk diffusion method: a single-center study in Odisha, India","volume":"15","author":"Nayak G","year":"2022","unstructured":"Nayak G, Behera B, Mohanty S, Kar P, Jena J. Analysis of in vitro activity of cefiderocol against carbapenem-resistant Gram-negative bacilli by broth microdilution and disk diffusion method: a single-center study in Odisha, India. Infect Drug Resist. 2022, 15:5887-97. 10.2147\/IDR.S366829","journal-title":"Infect Drug Resist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/277936-surveillance-of-in-vitro-activity-of-cefiderocol-against-carbapenem-resistant-gram-negative-clinical-isolates-in-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T07:20:28Z","timestamp":1724052028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/277936-surveillance-of-in-vitro-activity-of-cefiderocol-against-carbapenem-resistant-gram-negative-clinical-isolates-in-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.67164","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,19]]}}}